You are here
New relief for joint injuries
Piramal Healthcare (Canada) Ltd. is poised to launch a new natural gel that will provide relief to people suffering from cartilage injuries in their knees and other joints. A Canadian subsidiary of a multinational health products company, Piramal Healthcare (Canada) is vying for a piece of the global market for cartilage repair ― which it estimates to be worth about $1 billion ― with BST-Cargel®, which stimulates cartilage regeneration. Piramal Healthcare (Canada) employs 18 people in Laval, Que. and approximately 125 at its plant in Aurora, Ont.
Discovered by Michael Buschmann and Caroline Hoemann at École Polytechnique de Montréal, the gel adheres to damaged cartilage tissue, allowing it to rebuild and eventually repair itself.
BST-CarGel® offers a minimally invasive approach to treat cartilage injury, and is significantly less expensive than other treatments. Endorsed by retired Montreal Canadiens defenceman Serge Savard, who test-ran CarGel with positive results, it holds promise for sports medicine.
BST CarGel® is awaiting approval in Canada, but has been approved and commercialized for use in Europe.